Conference Coverage

Morning and evening skin care: What to tell patients


 

REPORTING FROM SDEF HAWAII DERMATOLOGY SEMINAR

“Protect and prevent” by applying an antioxidant and sunscreen in the morning, and focus on repair using a retinoid in the evening. That’s the simple message about daily skin care that clinicians can offer patients, according to Brooke Sikora, MD.

“At a very basic level, you want to tell your patients [to] use an antioxidant and use your sunscreen” early in the day, said Dr. Sikora, who is in private practice in Chestnut Hill, Mass. “In the evening, it’s all about repairing their damage, so make sure they’re getting on a retinol,” and if they can’t tolerate prescription strength, try a nonprescription product, she noted at the Hawaii Dermatology Seminar provided by Global Academy for Medical Education/Skin Disease Education Foundation.

“Aging factors create oxidative stress on the skin that leads to the development of these reactive oxygen species on the skin,” decreasing collagen production and increasing collagen breakdown, she explained during a presentation on cosmeceuticals at the meeting. Applying an antioxidant to the skin, however, can help neutralize “a lot of these reactive oxygen species and help to slow the breakdown of collagen.”

There is good evidence that peptides and growth factors – although expensive – work well and are worth recommending for patients “who really want to take their skin care to the next level,” Dr. Sikora said. “Then you can add corrective products like hyperpigmentation or acne products to treat ... specific concerns” as needed.

In an interview at the meeting, Dr. Sikora discussed these recommendations, as well as vitamin C use in the daily skin care routine. (To listen to the interview, click on the play button below.)

Vitamin C is the best-studied antioxidant, she noted during her presentation, and in vivo studies have shown it can stimulate collagen synthesis, reduce erythema of rosacea (which is why she has all her rosacea patients on vitamin C), reduce post-UVB erythema, decrease facial wrinkles, and increase dermal papillae.

Dr. Sikora disclosed that she is a consultant to and on the advisory board of SkinCeuticals, La Roche–Posay, Silk Therapeutics, Galderma, Evolus, and Allergen. She is on the speakers bureau for SkinCeuticals, La Roche–Posay, Galderma, and Aclaris.

SDEF/Global Academy for Medical Education and this news organization are owned by the same parent company.

To listen to the interview, click on the play button below.

Recommended Reading

Makeup is contaminated with pathogenic bacteria
MDedge Dermatology
Pyrrolidone carboxylic acid may be a key cutaneous biomarker
MDedge Dermatology
CD1a and cosmetic-related contact dermatitis
MDedge Dermatology
Lasers expunge mucosal tattoos
MDedge Dermatology
Social media may negatively influence acne treatment
MDedge Dermatology
Racial Limitations of Fitzpatrick Skin Type
MDedge Dermatology
Cosmeceutical ingredients to use before and after antiaging procedures
MDedge Dermatology
Vascular occlusion management
MDedge Dermatology
Data back botulinum toxin for facial flushing, androgenetic alopecia
MDedge Dermatology
Patient counseling about what to expect with noninvasive skin tightening is key
MDedge Dermatology